Inventor
WALCZAK ROBERT
FR25 patents
⚠️ This page may combine multiple inventors who share the name “WALCZAK ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENFIT
24 patentsUS11590108B2Feb 28, 2023
Pharmaceutical compositions for combination therapy
GENFIT9 citations83
US11974997B2May 7, 2024
RORgamma modulators and uses thereof
GENFIT7 citations82
US11478440B2Oct 25, 2022
Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent
GENFIT10 citations82
US11484517B2Nov 1, 2022
Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor
GENFIT10 citations81
US12053456B2Aug 6, 2024
Pharmaceutical compositions for combination therapy
GENFIT3 citations72
US11052092B2Jul 6, 2021
N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
GENFIT3 citations70
US11033534B2Jun 15, 2021
Pharmaceutical compositions for combination therapy
GENFIT3 citations70
US10653678B2May 19, 2020
Methods of treatment for cholestatic and fibrotic diseases
GENFIT3 citations70
US9902725B2Feb 27, 2018
Heterocyclic derivatives as RORgamma modulators
GENFIT4 citations68
US12208087B2Jan 28, 2025
Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation
GENFIT1 citations61
US11191749B2Dec 7, 2021
Pharmaceutical compositions for combination therapy
GENFIT1 citations60
US11103484B2Aug 31, 2021
Methods of treatment for cholestatic and fibrotic diseases
GENFIT0 citations60
US10905680B2Feb 2, 2021
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10130612B2Nov 20, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10130613B2Nov 20, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10117855B2Nov 6, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US10117856B2Nov 6, 2018
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations60
US11400078B2Aug 2, 2022
Methods of treatment for cholestatic and fibrotic diseases
GENFIT1 citations59
US11160801B2Nov 2, 2021
RORgamma modulators and uses thereof
GENFIT0 citations59
US12458612B2Nov 4, 2025
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists
GENFIT0 citations58
US10792277B2Oct 6, 2020
Methods of treatment of fibrosis and cancers
GENFIT0 citations50
US11077115B2Aug 3, 2021
Rorgamma modulators and uses thereof
GENFIT0 citations48
US10987351B2Apr 27, 2021
RORgamma modulators and uses thereof
GENFIT0 citations48
US12391712B2Aug 19, 2025
Phosphate derivatives of RORgamma modulators and uses thereof
GENFIT0 citations41